FLT3 and acute myeloid leukemia: AML exhibits significant genetic and molecular heterogeneity, with a complex range of gene mutations and chromosomal abnormalities, including key alterations in genes such as FLT3, NPM1, DNMT3A, and TP53 in AML patients (Ali and Salih, 2023).